Danazol inhibits steroidogenesis by the human ovary in vivo
- 1 May 1986
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 45 (5), 649-654
- https://doi.org/10.1016/s0015-0282(16)49336-2
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Serum hormone and steroid hormone receptor levels during luteal-phase and long-term treatment with danazolFertility and Sterility, 1983
- Danazol Suppresses Luteal Function in Vitro and in VivoFertility and Sterility, 1980
- Inhibition of Adrenal Steroidogenesis by Danazol in Vivo**Presented at the Thirty-Sixth Annual Meeting of The American Fertility Society, March 18 to 22, 1980, Houston, Tex.Fertility and Sterility, 1980
- Mechanism of induction of luteal phase defects by danazolAmerican Journal of Obstetrics and Gynecology, 1980
- Effect of danazol on estradiol-17β and progesterone secretion by porcine ovarian cells in vitroAmerican Journal of Obstetrics and Gynecology, 1979
- Circulating gonadotropins, estrogens, and androgens in polycystic ovarian diseaseAmerican Journal of Obstetrics and Gynecology, 1975
- Effects of Castration of Immature Rats on Serum FSH and LH, and of Various Steroid Treatments after Castration1Biology of Reproduction, 1974
- Elucidation of Mechanism(s) of the Nocturnal Rise of Testosterone in MenJournal of Clinical Endocrinology & Metabolism, 1974
- Radioimmunoassay of Plasma Dehydroepiandrosterone SulfateAnalytical Letters, 1972
- Danazol—a Synthetic Steroid Derivative with Interesting Physiologic PropertiesFertility and Sterility, 1971